Oncorus
Oncolytic Virus Cancer Immunotherapy
3
Funding Rounds
$140.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Do***** Fa******* | - | - | |
| Mi****** H. Fi*** | - | - | |
| Lu** Ev*** | - | - | - |
| Te* As***** | - | - | - |
| Ba***** Ya*** | - | - | - |
| Ma** Ka* Fe**** | - | - | |
| Sp***** Na* | - | - | - |
Funding series
Funding Series Analysis
The company Oncorus has raised a total of $57m in funding over 3 rounds.
Key Insights:
- Oncorus Series A round, July 2016: $57m
- Oncorus funding round, August 2019: $79.5m
- Oncorus Series A round December 2016: $4m
Oncorus Series A round, July 2016
$57m
Oncorus funding round, August 2019
$79.5m
Oncorus Series A round December 2016
$4m
Industries
Oncorus is active in the following industries:
- Immunotherapy
- Biomedical engineering
- Oncolytic virus
- Cancer
- Oncology
- Internal medicine
- Healthcare
- Medicine
- Speciality chemicals
- Engineering